Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $53.00 and last traded at $52.69, with a volume of 86901 shares changing hands. The stock had previously closed at $51.73. Analysts Set New Price Targets Several […]
Tandem Diabetes Care (NASDAQ:TNDM – Free Report) had its target price hoisted by Stifel Nicolaus from $45.00 to $55.00 in a research note published on Wednesday morning, Benzinga reports. The firm currently has a buy rating on the medical device company’s stock. Other analysts also recently issued research reports about the stock. Leerink Partnrs upgraded […]
Victory Capital Management Inc. lowered its position in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Free Report) by 86.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 13,484 shares of the medical device company’s stock after selling 85,256 shares during the quarter. Victory […]
Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) saw unusually large options trading activity on Tuesday. Stock investors acquired 6,339 call options on the stock. This is an increase of approximately 620% compared to the average daily volume of 880 call options. Tandem Diabetes Care Stock Up 4.4 % Shares of NASDAQ TNDM opened […]
Tandem Diabetes Care (NASDAQ:TNDM – Get Free Report)‘s stock had its “overweight” rating restated by analysts at Piper Sandler in a report issued on Friday, Benzinga reports. They presently have a $50.00 price objective on the medical device company’s stock, up from their prior price objective of $35.00. Piper Sandler’s price target points to a […]